Dr Daniel C. Anthony

Dr Anthony joined the Department in 2004 from Southampton University (1998-2004). While he was there, in collaboration with Professor Hugh Perry, the hepatic chemokine response to acute injury was discovered and the Molecular Neuropathology Laboratory (now the Experimental Neuropathology Laboratory was established). Our independent laboratory is recognised both nationally and internationally and has close ties with Professor Perry's CNS Inflammation Group, Southampton and the Dr Sibson’s Experimental Neuroimaging Group, Oxford. Dr Anthony is continuing with the strategy of combining state-of-the-art MRI and bioluminesence imaging with and molecular biology and immuno techniques to discover how inflammation contributes to CNS injury and disease.

Dr Anthony was a Glaxo graduate student in the Department of Surgery, University College London where he worked with Professor Paul Boulos examining the role of metalloproteinases in Inflammatory Bowel Disease. Following the completion of his PhD in 1994, Dr Anthony joined Professor Hugh Perry, then in Oxford, on a British Biotech fellowship investigating metalloproteinase expression in the CNS. It was during this period that he became interested in the leukocyte-mediated mechanisms of neurodegeneration. Dr Anthony also held a position as retained lecturer at Trinity College Oxford in this period (1994-1998).

Committees and Honours:
MRC Brain Sciences Panel, MRC College of Experts, MSc Programme Manager Committee, Oxford University, Member of Governing Body, Somerville College.